Gilead Sciences Inc (GILD)

NASDAQ HEALTHCARE

$123.76 -1.35% RSI 43 Neutral Add Alert

Moving Averages

SMA 200

$128.96

Price below

Company Profile

Gilead Sciences, Inc. is an American biopharmaceutical company headquartered in Foster City, California, that focuses on researching and developing antiviral drugs used in the treatment of HIV, hepatitis B, hepatitis C, and influenza, including Harvoni and Sovaldi.

Sector

HEALTHCARE

Industry

DRUG MANUFACTURERS - GENERAL

Market Cap

$155.82B

P/E Ratio

17.07

EPS

$7.35

Beta

0.331